ETR:BAYN - Bayer Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €55.80 -1.15 (-2.02 %) (As of 05/20/2019 12:33 PM ET)Previous Close€56.95Today's Range€55.37 - €56.8652-Week Range€54.48 - €103.74Volume2.89 million shsAverage VolumeN/AMarket Capitalization$54.69 billionP/E Ratio54.98Dividend Yield4.72%BetaN/A ProfileChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University to jointly identify new drug targets for the treatment of pulmonary diseases, such as idiopathic pulmonary fibrosis. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Receive BAYN News and Ratings via Email Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ETR Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolETR:BAYN Previous Symbol CUSIPN/A CIKN/A Webwww.bayer.com Phone49 214 30 1Debt Debt-to-Equity Ratio87.64 Current Ratio1.37 Quick Ratio0.91Price-To-Earnings Trailing P/E Ratio54.98 Forward P/E Ratio7.45 P/E Growth2.17 Sales & Book Value Annual Sales$43.46 billion Price / Sales1.26 Cash Flow€4.86 per share Price / Cash Flow11.48 Book Value€48.88 per share Price / Book1.14Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees111,015 Outstanding Shares980,152,000Market Cap$54.69 billion Next Earnings Date7/30/2019 (Estimated) OptionableNot Optionable Bayer (ETR:BAYN) Frequently Asked Questions What is Bayer's stock symbol? Bayer trades on the ETR under the ticker symbol "BAYN." When is Bayer's next earnings date? Bayer is scheduled to release their next quarterly earnings announcement on Tuesday, July 30th 2019. View Earnings Estimates for Bayer. Has Bayer been receiving favorable news coverage? Press coverage about BAYN stock has been trending somewhat negative on Monday, according to InfoTrie. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Bayer earned a news impact score of -1.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. Who are some of Bayer's key competitors? Some companies that are related to Bayer include GlaxoSmithKline (GSK), AstraZeneca (AZN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Mayne Pharma Group (MYX), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY), Vita Life Sciences (VLS) and Futura Medical (FUM). What other stocks do shareholders of Bayer own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include DIGITAL RLTY TR/SH (DLR), NVIDIA (NVDA), Paypal (PYPL), American Tower (AMT), AvalonBay Communities (AVB), CVS Health (CVS), Enterprise Products Partners (EPD), General Electric (GE), Kimco Realty (KIM) and Altria Group (MO). Who are Bayer's key executives? Bayer's management team includes the folowing people: Mr. Werner Baumann, Chairman of Management & CEO (Age 57)Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63) What is Bayer's stock price today? One share of BAYN stock can currently be purchased for approximately €55.80. How big of a company is Bayer? Bayer has a market capitalization of $54.69 billion and generates $43.46 billion in revenue each year. Bayer employs 111,015 workers across the globe. What is Bayer's official website? The official website for Bayer is http://www.bayer.com. How can I contact Bayer? The company can be reached via phone at 49 214 30 1. MarketBeat Community Rating for Bayer (ETR BAYN)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 24 (Vote Outperform)Underperform Votes: 15 (Vote Underperform)Total Votes: 39MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Reverse Stock Split Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.